新規なミクロモノスポラ種からのバフィロマイシン-様代謝産物 - JANSSEN PHARMACEUTICA NAAMLOZE VENNOOTSCHAP

Title:

新規なミクロモノスポラ種からのバフィロマイシン-様代謝産物

Document Type and Number:

Japanese Patent JP2005534680

Kind Code:

A

Abstract:

The invention provides a compound of formula (I) and pharmaceutically acceptable salts thereof. Processes for the isolating of this bafilomycin metabolite from a novel Micromonospora species, pharmaceutical compositions containing this metabolite and methods of treatment using said metabolite are also described.

More Like This:

WO/1989/004821	N-(BIPHENYLMETHYL)-3-HYDROXYGLUTARAMIC ACID AND DERIVATIVES AS HYPOCHOLESTEROLEMIC AGENTS
JP6280129	A calcium flux agonist and a method for the same
JPH0667944	INDUSTRIAL APPLICABILITY [Title of Invention] 13-Substituted milbemycin derivative

Inventors:

Ban Doun, Jacobs Alphonseus Josephs
Wouters, Walter Boudewien Leopold
Jean-Marie, Michele Marie Francois
Mosek, Ursula Maria
Raxo, Jyodei Ann

Application Number:

JP2004518781A

Publication Date:

November 17, 2005

Filing Date:

June 30, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

JANSSEN PHARMACEUTICA NAAMLOZE VENNOOTSCHAP

International Classes:

A61K31/365; A61K31/70; A61K31/7048; A61P31/04; A61P35/00; C07D313/00; C12P17/16; C07H7/06; C07H17/04; C12N1/20; C12P17/14; C12R1/29; (IPC1-7): C07H7/06; A61K31/7048; A61P31/04; A61P35/00; C12N1/20; C12P17/16

Attorney, Agent or Firm:

Heikichi Odashima

Previous Patent: 治療的処置のための組成物および方法

Next Patent: キナーゼ阻害剤としてのトキソフラビンの３−フラニル類似物